Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Mattia Congia"'
Autor:
Andreina Manfredi, Marco Fornaro, Chiara Bazzani, Simone Perniola, Alberto Cauli, Alessandra Rai, Ennio Giulio Favalli, Serena Bugatti, Maurizio Rossini, Rosario Foti, Fabrizio Conti, Giuseppe Lopalco, Anna Scalvini, Cristina Garufi, Mattia Congia, Roberto Gorla, Elisa Gremese, Fabiola Atzeni, Roberto Caporali, Florenzo Iannone, Marco Sebastiani
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
ObjectivesAn increased number of elderly individuals affected by rheumatoid arthritis (RA) has been reported, including both patients with RA onset in advanced age and patients aged with the disease. In this registry-based study, we aimed to analyze
Externí odkaz:
https://doaj.org/article/709cea62acef41fabc2bb9cc1f10906c
Autor:
Alberto Cauli, Matteo Piga, Maria Maddalena Angioni, Alberto Floris, Mattia Congia, Alessandro Mathieu, Elisabetta Chessa, Alessandra Perra, Mauro Giovanni Carta, Luca Saba, Elisa Pintus, Michele Porcu, Cristina Serafini, Micaela Rita Naitza
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 2 (2023)
Objectives To explore the effects of anti-ribosomal P protein (anti-P) and anti-N-methyl-D-aspartic acid receptor subunit 2 (anti-NR2) autoantibodies on depression and cognitive dysfunction and their relationships with functional brain connectivity i
Externí odkaz:
https://doaj.org/article/50179793c21b413ebfaa4443c4c43137
Autor:
Maria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, Mattia Congia, Elisabetta Chessa, Micaela Rita Naitza, Matteo Piga, Alberto Cauli
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundIn psoriatic arthritis (PsA), the primary goal of treatment is clinical remission. This study aimed to characterize the molecular profile underlying the induced clinical remission in patients with PsA, comparing the remission state and the
Externí odkaz:
https://doaj.org/article/1d0074632abb40f5b5f41358e32ac843
Autor:
Cristina Cocco, Elias Manca, Giulia Corda, Maria Maddalena Angioni, Barbara Noli, Mattia Congia, Francesco Loy, Michela Isola, Elisabetta Chessa, Alberto Floris, Lorena Lorefice, Luca Saba, Alessandro Mathieu, Gian Luca Ferri, Alberto Cauli, Matteo Piga
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE) is widely unknown, and the role of autoantibodies is still undetermined.MethodsTo identify brain-reactive autoantibodies possibly related to NPSLE, immunofluorescen
Externí odkaz:
https://doaj.org/article/1ce6a1fb824747f3a0f1c6ddf8549621
Autor:
Arduino A. Mangoni, Richard J. Woodman, Matteo Piga, Alberto Cauli, Anna Laura Fedele, Elisa Gremese, Gian Luca Erre, The EDRA Study Group, Floriana Castagna, Marco Piras, Maria Luisa Cadoni, Loredana Taras, Ignazio Cangemi, Martina Dessì, Ilaria Platè, Elisabetta Chessa, Mattia Congia, Alberto Floris, Maria Giovanna Longu, Giuseppe Passiu, Dario Bruno, Gianfranco Ferraccioli
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Objectives: Specific anti-inflammatory and/or immunomodulating drugs (AIDs) can influence endothelial function which is often impaired in patients with rheumatoid arthritis (RA). We sought to determine whether overall patterns of AID usage are simila
Externí odkaz:
https://doaj.org/article/3398c0f43ec24cb4b619ab869f114cd8
Autor:
Alberto Floris, Mattia Congia, Elisabetta Chessa, Maria Maddalena Angioni, Matteo Piga, Alberto Cauli
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Specific and high-quality evidence on the efficacy of the current targeted therapies for axial disease in psoriatic arthritis (axPsA) is still scarce. Indeed, almost all the cohorts investigated in clinical trials on PsA consisted of patients with pe
Externí odkaz:
https://doaj.org/article/fdc3696cd2e540e89472021032f1712d
Autor:
Ricard Cervera, Marcello Govoni, Alberto Cauli, Matteo Piga, Alberto Floris, Mattia Congia, Alessandro Mathieu, Florenzo Iannone, George Bertsias, Luca Cantarini, Vincenzo Venerito, Giuseppe Lopalco, Antonio Vitale, Piergiorgio Neri, Carlos Vasconcelos, Raquel Faria, Gerard Espinosa, Elisabetta Chessa, Ignasi Rodriguez Pinto, Andrea Lo Monaco, GIOVANNI CIANCIO, Luísa Serpa Pinto, Nikolaos Kougkas, Ida Orlando, Vittorio Pirani, Ernestina Santos, João Correia, Ana Martins Silva, Monica Muntoni, Nestor Avgoustidis, Roberto Rios Garcés, Giulio Guerrini, Gema Lledó Ibáñez, Piero Mascia
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Objective To develop and validate the evidence-based and consensus-based Behçet’s Syndrome Overall Damage Index (BODI).Methods Starting from 120 literature-retrieved preliminary items, the BODI underwent multiple Delphi rounds with an internationa
Externí odkaz:
https://doaj.org/article/86a4379847224c1fbe859c2869e3c73f
Autor:
Matteo Piga, Alberto Floris, Giulia Cappellazzo, Elisabetta Chessa, Mattia Congia, Alessandro Mathieu, Alberto Cauli
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-9 (2017)
Abstract Background The aim was to assess the attainability and outcome of the lupus low disease activity state (LLDAS) in the early stages of systemic lupus erythematosus (SLE). Methods LLDAS prevalence was evaluated at 6 (T1) and 18 (T2) months aft
Externí odkaz:
https://doaj.org/article/f11b131a263248e283f79b7ef52cd847
Autor:
Robert J Moots, Pier Paolo Sainaghi, Mattia Congia, Bernard Lauwerys, Rebecca Hands, Christopher Holroyd, Nagui Gendi, Carlomaurizio Montecucco, Louise Warren, Ernest Choy, Gaye Hadfield, Serena Bugatti, Mattia Bellan, Joanna Peel, Georgina Thorborn, Arthur G. Pratt, Julio A. Ramirez, Vasco C. Romão, Nora Ng, Stephen Kelly, John D. Isaacs, Felice Rivellese, Raquel Celis, Peter C. Taylor, Christopher J Edwards, Frances Humby, Giovanni Giorli, Patrick Verschueren, Maya H Buch, Costantino Pitzalis, Pauline Ho, Alessandra Nerviani, Piero Reynolds, Charlotte Thompson, Liliane Fossati-Jimack, João Eurico Fonseca, Juan D. Cañete, Peter Sasieni, Patrick Durez, Myles Lewis, Alberto Cauli, Arti Mahto, Laura White, Bhaskar Dasgupta, Hasan Rizvi, Michele Bombardieri
Publikováno v:
Lancet (London, England), Vol. 397, no.10271, p. 305-317 (2021)
Lancet (London, England)
Lancet (London, England)
BACKGROUND: Although targeted biological treatments have transformed the outlook for patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is mechanistically still unexplained. Because more than 50% of patients with r
Autor:
Daniela Perra, Elisabetta Chessa, Matteo Piga, Alberto Cauli, Mattia Congia, Alessandro Mathieu, Alberto Floris
Publikováno v:
Arthritis Care & Research. 72:1794-1799
OBJECTIVE To compare the effect of achievement and maintenance of Lupus Low Disease Activity State (LLDAS) and clinical remission (CR) in preventing early damage accrual in patients with systemic lupus erythematosus (SLE). METHODS In a monocentric co